At day 7 post-infection a tendency towards a reduction of GP33-specific CD8 T cells was observed in the spleen and particularly in the PDLN of anti-JAM-C antibody-treated mice compared to control animals (Figure 5A). The gene discussed is JAM3; the disease is infection.